Screener
MBX Biosciences, Inc. MBX Current ratio
Current ratio at other companies
Other financials
Where this comes from
Calculated from MBX Biosciences, Inc.’s reported figures.
Based on the most recent quarter.
The source filing: MBX Biosciences, Inc.’s 10-Q, filed May 7, 2026. Open the filing →
- Filed
- May 7, 2026, 9:03 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-210593
FAQ
- What is MBX Biosciences, Inc.'s current ratio?
- MBX Biosciences, Inc. (MBX) reported current ratio of 30.8× in Q1 2026.
- How has MBX Biosciences, Inc.'s current ratio changed year-over-year?
- MBX Biosciences, Inc.'s current ratio increased by 32.1% year-over-year, from 23.3× to 30.8×.
- What is the long-term trend for MBX Biosciences, Inc.'s current ratio?
- Over 2 years (2023 to 2025), MBX Biosciences, Inc.'s current ratio has grown at a 7.6% compound annual growth rate (CAGR), from 21.3× to 24.6×.
- What does current ratio mean?
- Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.
Ask your AI about MBX Biosciences, Inc.'s current ratio.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude